When did DR. REDDY'S LABORATORIES-ADR (RDY) report earnings last quarter?
DR. REDDY'S LABORATORIES-ADR (RDY) last reported earnings on 1/21/2026.
DR. REDDY'S LABORATORIES-ADR (RDY) Earnings History & Surprises
NYSE:RDY • US2561352038
Current stock price
13.46 USD
-0.02 (-0.15%)
At close:
13.46 USD
0 (0%)
After Hours:
RDY Earnings overview
Past quarterly earnings results for DR. REDDY'S LABORATORIES-ADR (RDY), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 7, 2026
- Period
- Q4 / 2026
- EPS Estimate
- ₹13.38
- Revenue Estimate
- 87.118B
Last Reported
Most Recent- Release Date
- Jan 21, 2026
- Period
- Q3 / 2026
- EPS Reported
- ₹14.53
- EPS Surprise
- 4.69%
- Revenue Surprise
- 2.40%
Beat Rate
Last 8 Quarters 50%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in INR): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2026 | 14.53 | 13.88 | 4.69% | -14.29% | 87.534B | 85.484B | 2.40% | 4.44% |
| Q2 2026 | 16.18 | 17.69 | -8.52% | 7.44% | 88.283B | 89.633B | -1.51% | 9.83% |
| Q1 2026 | 17.03 | 18.26 | -6.74% | 1.94% | 85.721B | 89.177B | -3.88% | 11.38% |
| Q4 2025 | 19.12 | 18.60 | 2.77% | 21.89% | 85.284B | 85.641B | -0.42% | 19.89% |
| Q3 2025 | 16.95 | 17.52 | -3.24% | 2.28% | 83.812B | 82.986B | 1.00% | 15.81% |
| Q2 2025 | 15.06 | 17.33 | -13.10% | -15.36% | 80.382B | 78.202B | 2.79% | 16.45% |
| Q1 2025 | 16.71 | 15.66 | 6.71% | -1.04% | 76.961B | 74.271B | 3.62% | 13.88% |
| Q4 2024 | 15.68 | 14.96 | 4.81% | 35.84% | 71.138B | 72.58B | -1.99% | 12.65% |
| Q3 2024 | 16.58 | 15.10 | 9.80% | 10.77% | 72.368B | 70.667B | 2.41% | 6.58% |
| Q2 2024 | 17.80 | 14.80 | 20.25% | 32.74% | 69.026B | 69.536B | -0.73% | 9.01% |
| Q1 2024 | 16.89 | 12.40 | 36.15% | 18.00% | 67.579B | 66.455B | 1.69% | 29.14% |
| Q4 2023 | 11.55 | 9.80 | 17.78% | 889.37% | 63.152B | 61.607B | 2.51% | 15.35% |
| Q3 2023 | 14.96 | 13.22 | 13.23% | 75.99% | 67.898B | 62.062B | 9.40% | 27.19% |
| Q2 2023 | 13.41 | 9.64 | 39.15% | 12.29% | 63.318B | 58.494B | 8.25% | 9.42% |
| Q1 2023 | 14.31 | 7.78 | 84.05% | 108.18% | 52.329B | 54.772B | -4.46% | 5.82% |
| Q4 2022 | 1.17 | 8.10 | -85.59% | -82.49% | 54.749B | 52.723B | 3.84% | 14.82% |
| Q3 2022 | 8.50 | 8.98 | -5.31% | 3,469.75% | 53.383B | 55.205B | -3.30% | 8.02% |
| Q2 2022 | 11.94 | 8.22 | 45.28% | 30.15% | 57.869B | 52.999B | 9.19% | 17.84% |
| Q1 2022 | 6.87 | 8.05 | -14.61% | -1.49% | 49.451B | 52.74B | -6.24% | 11.72% |
| Q4 2021 | 6.66 | 7.96 | -16.25% | -27.71% | 47.682B | 49.377B | -3.43% | 7.18% |
| Q3 2021 | 0.24 | 8.81 | -97.30% | 103.46% | 49.419B | 51.608B | -4.24% | 12.39% |
| Q2 2021 | 9.17 | 7.45 | 23.09% | -30.37% | 49.109B | 47.456B | 3.48% | 2.04% |
| Q1 2021 | 6.98 | 6.20 | 12.57% | -12.65% | 44.265B | 42.656B | 3.77% | 14.73% |
| Q4 2020 | 9.22 | 6.56 | 40.44% | - | 44.489B | 43.094B | 3.24% | - |
| Q3 2020 | -6.88 | 6.00 | -214.68% | - | 43.971B | 43.062B | 2.11% | - |
| Q2 2020 | 13.17 | 6.87 | 91.86% | - | 48.128B | 43.273B | 11.22% | - |
| Q1 2020 | 7.99 | 5.59 | 42.99% | - | 38.582B | 40.815B | -5.47% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-3.93%
Max EPS beat (4)
2.77%
Min EPS beat (4)
-8.52%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
-1.20%
Max Revenue beat (4)
1.00%
Min Revenue beat (4)
-3.88%
Analysis
In the last 4 quarters, RDY has beaten EPS estimates in 1 out of 4 releases
RDY has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, RDY reported -3.9% below the EPS estimates on average.
In the last 4 quarters, RDY reported -1.2% below the revenue estimates on average.
Related analysis
DR. REDDY'S LABORATORIES-ADR / RDY Earnings FAQ
Did DR. REDDY'S LABORATORIES-ADR (RDY) beat earnings estimates last quarter?
DR. REDDY'S LABORATORIES-ADR (RDY) beat EPS estimates and beat revenue estimates in the most recent quarter.
What percentage of the time does RDY stock beat earnings estimates?
In the last 4 quarters, DR. REDDY'S LABORATORIES-ADR (RDY) has beaten EPS estimates in 1 out of 4 releases.